Status: Phase 1
Entry Type: Antibody
Molecule Category: UNKNOWN

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Transferrin receptor inhibitor Other

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Myelodysplastic Syndromes 1 D009190 ClinicalTrials
Leukemia 1 D007938 ClinicalTrials
Multiple Myeloma 1 D009101 ClinicalTrials
Myeloproliferative Disorders 1 D009196 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2109495